Menu
Back to Journals » Pharmacogenomics and Personalized Medicine » Volume 14
Pathway to Ascertain the Role of Pharmacogenomics in Healthcare Utilization Outcomes [Letter]
Authors Roman YM
Received 1 March 2021
Accepted for publication 15 March 2021
Published 26 March 2021 Volume 2021:14 Pages 379—380
DOI https://doi.org/10.2147/PGPM.S309038
Checked for plagiarism Yes
Editor who approved publication: Dr Martin Bluth
Youssef M Roman
Department of Pharmacotherapy and Outcomes Science, Virginia Commonwealth University School of Pharmacy, Richmond, VA, 23298, USA
Correspondence: Youssef M Roman
Department of Pharmacotherapy and Outcomes Science, Virginia Commonwealth University School of Pharmacy, Richmond, VA, 23298, USA
Email [email protected]
I read with great interest and excitement the findings published in your journal by Takahashi1 and colleagues investigating the association between select pharmacogenetic variants and hospitalization and emergency department (ED) visits. However, I would like to share some comments regarding the study that have not been addressed in the original manuscript.
View the original paper by Takahashi and colleagues
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.